Skip to main content
Signal8

ENvue Medical, Inc. (FEED)

NanoVibronix, Inc. focuses on developing non-surgical medical devices that stimulate biological responses. Its core offerings include UroShield and PainShield. The company's business activities span across several global markets, such as the United States, Europe, Australia, India, and Israel, in addition to other territories. This enterprise was founded by Harold Jacob and Jona Zumeris in September 2003, and its main corporate office is situated in Tyler, Texas.

Sector: Orthopedic, Prosthetic & Surgical Appliances & Supplies

Industry: Medical - Specialties

ENvue Medical, Inc. logo

ENvue Medical, Inc.

OTC:FEEDOTC (suspended from Nasdaq on Sep 16, 2026)Healthcare
+26.92%$0.3300
Mkt Cap$305K
EV-
Float772K
O/S924K
VOL2K sh
$ Vol$483
RVOL0.10×
Inst Own-
SI3.1%
Net Cash/Sh-
Dilution
ENvue Medical, Inc. logoOTC:FEED$0.3300+26.92%

ENvue Medical, Inc. (FEED) dilution facts from SEC filings

Snapshot as of Jun 30, 2026, built from 38 SEC filings.

Shelf registration
S-3 filed Aug 10, 2026, effective Sep 3, 2026
Source: EFFECT filed Sep 3, 2026
At-the-market (ATM) program
No active program in the filings reviewed
Warrants outstanding
7 warrant series recorded as outstanding
Most recent offering
PIPE, closed Aug 5, 2026
Source: 10-Q filed Aug 17, 2026

Check another stock for dilution

Facts as recorded in the company's SEC filings. The full snapshot, with instrument terms, share counts and history, is part of Signal8 Pro.

Unlock with Signal8 Pro